Shanghai, China

Wenli Tian

USPTO Granted Patents = 1 

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2025

where 'Filed Patents' based on already Granted Patents

1 patent (USPTO):

Title: The Innovations of Inventor Wenli Tian

Introduction: Wenli Tian, an accomplished inventor based in Shanghai, China, has made significant contributions to the field of biotechnology. With a focus on developing advanced medical solutions, his work exemplifies the role of innovation in enhancing healthcare.

Latest Patents: Wenli Tian holds one notable patent entitled "Recombinant herpes zoster vaccine composition and application thereof." This invention discloses a novel recombinant vaccine composition that, when compared to other antigen and adjuvant combinations, demonstrates a more beneficial immune effect. This ground-breaking work has the potential to greatly improve vaccine efficacy in combating herpes zoster.

Career Highlights: Currently, Wenli Tian is affiliated with Immune-Path Biotechnology (Suzhou) Co., Ltd., where he leverages his expertise to drive research and innovation. His dedication to advancing vaccine development and his successful patent exemplify his commitment to the field.

Collaborations: Throughout his career, Wenli Tian has collaborated with talented professionals, including his coworkers Li Shi and Zhi Zhang. These partnerships have enhanced the scope of his research and have contributed to the successful development of patents and innovations in biomedicine.

Conclusion: Wenli Tian's contributions to the field of biotechnology, particularly in vaccine development, demonstrate the importance of innovation and collaboration. His patented work not only highlights his inventive spirit but also underscores the role of dedicated professionals in advancing healthcare solutions. As he continues to innovate, the impact of his work will be felt in the broader medical community.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…